Treatment adherence behaviours in rheumatic diseases during COVID-19 pandemic: a Latin American experience

Pineda-Sic, R.; Galarza‐Delgado, Dionicio Ángel; Serna-Peña, Griselda; Castillo‐Torres, Sergio A.; Flores-Alvarado, Diana Elsa; Esquivel-Valerio, Jorge Antonio; Hernandez-Galarza, I. D. J.

doi:10.1136/annrheumdis-2020-218198

Cited by 24 publications

(24 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This could be due to either inadequate supply of medications from defaulting follow-ups or poor compliance due to fear. Pineda-Sic et al 6 reported that lack of availability of medications and fear of getting sick from COVID-19 were factors for changes or suspension in medications.…”

mentioning

confidence: 99%

Impact of lockdown on rheumatology outpatient care in the age of COVID-19

et al. 2020

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Impact of lockdown on rheumatology outpatient care in the age of COVID-19

et al. 2020

View full text Add to dashboard Cite

show abstract

“…As some studies have shown COVID-19 has changed the perceptions of patients with RA about their medications and the uncertainties about the safety of them (12)(13)(14). Additional to these concerns, there is an enormous amount of false information provided by the internet or social network during these days (15).…”

Section: Discussionmentioning

confidence: 99%

Practices and Behaviors During the COVID-19 Pandemic in Patients With Rheumatoid Arthritis Who Attended Previously to An Educational Program. A Cross-Sectional Study

Santos-Moreno¹,

Buitrago-Garcia

Rodriguez-Florido³

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: To describe the practices and behaviors of patients with rheumatoid arthritis (RA) who attend to a face-to-face education program, during the quarantine of the COVID-19 pandemic. Methods: Patients who attended previously a face-to-face education program, responded to a telephonic survey in July 2020. The survey included questions about their practices related to the COVID-19 pandemic, SARS-Cov-2 symptoms, adherence to rheumatoid arthritis treatment, virtual rheumatology consultancy compliance and, the influence of news on their adherence. Results: A total of 260 patients participated in a survey. In July 2020 88% of patients had accessed a telemedicine-based and 12% a face-to-face rheumatology consultation. 3.5% of patients reported having been less adherent to pharmacological therapy due to information received through media or social networks. In general patients had been compliant with COVID-19 prevention recommendations. Only one patient was positive for SARS-CoV-2 and reported only flu symptoms without any complications. Patients highlighted the necessity to have information and education about the relationship between rheumatoid arthritis, its treatment, and COVID-19. Conclusions: An educational program is a helpful tool to maintain high adherence rates to the RA treatment despite of the new challenges associated to the pandemic; Patient-centered education programs should continue to address the patient's concerns and beliefs about their disease and COVID-19.

show abstract

“…A similar survey in Mexico from a single outpatient center showed 15% (52/345) of respondents reported some form of medication nonadherence, of which 48.1% (25/52) was due to lack of drug availability and 25% (13/52) was due to concerns about contracting COVID-19 34 . In a survey from Saudi Arabia with 591 respondents who were actively taking medication prescribed for rheumatic diseases, 47.9% reported difficulty filling their prescription, 29.5% had self-altered (dose escalation, discontinuation, and reduction) their medications, and 31.9% were unable to attend rheumatology follow up visits due to local quarantine restrictions 35 .…”

Section: Impact Of Covid-19 On Patients With Inflammatory Arthritismentioning

confidence: 93%

Inflammatory arthritis in patients with COVID-19

Conway

Konig

Graef³

et al. 2021

Translational Research

View full text Add to dashboard Cite

Patients with inflammatory arthritis represent a possible high-risk group to COVID-19 due to their immunosuppressive regimen designed to maintain low disease activity. Thus, substantial effort has been put forth to understand the impact of COVID-19 on these patients. Patients with rheumatic diseases as a whole do not appear to be more susceptible to acquiring COVID-19. Furthermore, immunosuppression generally did not increase the likelihood of developing severe COVID-19, with the important exception of medium and high-dose glucocorticoid use. In addition, a small number of COVID-19 patients have developed new inflammatory arthritis; whether this represents an unmasking of previous subclinical disease or a bone fide virus-induced arthritis is unclear. Nevertheless, it appears that inflammatory arthritis patients currently on immunosuppression should continue their medication to prevent future flares and limit glucocorticoid usage. While this continues to be a rapidly evolving field, these data are reassuring to both patients with and providers treating inflammatory arthritides.

show abstract

Treatment adherence behaviours in rheumatic diseases during COVID-19 pandemic: a Latin American experience

Cited by 24 publications

References 5 publications

Impact of lockdown on rheumatology outpatient care in the age of COVID-19

Impact of lockdown on rheumatology outpatient care in the age of COVID-19

Practices and Behaviors During the COVID-19 Pandemic in Patients With Rheumatoid Arthritis Who Attended Previously to An Educational Program. A Cross-Sectional Study

Inflammatory arthritis in patients with COVID-19

Contact Info

Product

Resources

About